Tiffany A. LaFortune

Author

The University of Texas MD Anderson Cancer Center

Also Known As

T A LaFortune, T. LaFortune, T. Lafortune, Tiffany A. LaFortune, Tiffany A. Lafortune, Tiffany LaFortune, Tiffany Lafortune

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Novartis Institutes for BioMedical Research Novartis (Switzerland)

About

Tiffany A. LaFortune is an author at The University of Texas MD Anderson Cancer Center specializing in health sciences, matrix biology, and cell proliferation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	23
2	Medicine	1	1	23
3	Cell Biology	1	1	23
4	Pathology	1	1	23
5	Cancer Therapeutics	1	1	23

Tiffany A. LaFortune

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas Ta-Jen Liu, Dimpy Koul, Tiffany A. LaFortune, Molecular Cancer Therapeutics	2009	249
Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation <i>in vitro</i> and <i>in vivo</i> Ta-Jen Liu, Tiffany A. LaFortune, Toshiyuki Honda, Molecular Cancer Therapeutics	2007	203
Antitumor Activity of NVP-BKM120—A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells Dimpy Koul, Jun Fu, Ruijun Shen, Clinical Cancer Research	2011	182
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer Dongwei Zhang, Tiffany A. LaFortune, Savitri Krishnamurthy, Clinical Cancer Research	2009	130
Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma Vanessa Milano, Yuji Piao, Tiffany A. LaFortune, Molecular Cancer Therapeutics	2009	120
Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma Dimpy Koul, Ruijun Shen, Sherry Bergh, Molecular Cancer Therapeutics	2006	92
Cell Cycle–Dependent Nuclear Export of Phosphatase and Tensin Homologue Tumor Suppressor Is Regulated by the Phosphoinositide-3-Kinase Signaling Cascade Juinn-Lin Liu, Zhenyu Mao, Tiffany A. LaFortune, Cancer Research	2007	52
PEA-15 unphosphorylated at both serine 104 and serine 116 inhibits ovarian cancer cell tumorigenicity and progression through blocking β-catenin J. Jack Lee, Chandra Bartholomeusz, P Liu, Oncogenesis	2012	42
Silencing Kinase-Interacting Stathmin Gene Enhances Erlotinib Sensitivity by Inhibiting Ser10 p27 Phosphorylation in Epidermal Growth Factor Receptor–Expressing Breast Cancer Dongwei Zhang, Ana M. Tari, Uǧur Akar, Molecular Cancer Therapeutics	2010	23
Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapy Su Guan, Rulong Shen, Tiffany A. LaFortune, Neuro-Oncology Relevant ModelsVimentin ExpressionPathologyCell ProliferationTrue Challenge	2011	23

Page 1